- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | ADDvise Group AB (publ): Amplex has increased the consideration in the public offer to the shareholders and warrant holders of ADDVise | 11 | GlobeNewswire (Europe) | On 10 December 2025, Amplex AB ("Amplex" or the "Bidder") announced a public offer to the shareholders and warrant holders of ADDvise Group AB (publ) ("ADDvise" or the "Company") to transfer all shares... ► Artikel lesen | |
| Fr | Amplex AB publishes supplement to the offer document regarding the cash offer to the shareholders and warrantholders of ADDvise Group AB (publ) | 1 | Cision News | ||
| Fr | AMPLEX AB: Amplex increases the consideration in the cash offer to the shareholders and warrantholders of ADDvise and enters into agreements on conditional acquisitions of shares and warrants in ADDvise | 3 | Cision News | ||
| 10.12. | ADDvise Group AB (publ) receives observation status | 244 | GlobeNewswire | Today, December 10, 2025, Amplex AB disclosed a public offer to the other shareholders and equity rights holders of ADDvise Group AB (publ).
The rules of Nasdaq First North Growth Market state... ► Artikel lesen | |
| ADDVISE GROUP Aktie jetzt für 0€ handeln | |||||
| 10.12. | AMPLEX AB: Amplex publishes the offer document for the public cash offer to the shareholders and warrantholders of ADDvise Group AB (publ) | 4 | Cision News | ||
| 10.12. | Amplex AB announces a cash offer to the shareholders and warrantholders of ADDvise Group AB (publ) | 7 | Cision News | ||
| 10.12. | ADDvise Group AB (publ): ADDvise's board of directors evaluates the public offer from Amplex | 122 | GlobeNewswire (Europe) | Amplex AB ("Amplex") has today announced a public offer to the shareholders and warrant holders of ADDvise Group AB (publ) ("ADDvise") to transfer all shares and warrants in ADDvise to Amplex at a price... ► Artikel lesen | |
| 12.11. | ADDvise Group AB (publ): ADDvise receives order worth USD 2.3 million | 134 | GlobeNewswire (Europe) | ADDvise Group's subsidiary MRC Systems has received an order from IPS. IPS are a global engineering firm that delivers complex projects within life science. The order is worth approximately USD 2.3... ► Artikel lesen | |
| 23.10. | ADDvise Group AB (publ): Interim report 2025, January 1-September 30 | 120 | GlobeNewswire (Europe) | Strengthened profitability and cash flow despite a quarter with macro headwinds. In the third quarter, organic sales decreased by 4.8% in constant currency, but the year-to-date growth remains positive.... ► Artikel lesen | |
| 17.07. | ADDvise Group AB (publ): Interim report 2025, January 1-June 30 | 152 | GlobeNewswire (Europe) | In the second quarter of 2025, organic sales adjusted for currency effects increased, driven by steady demand for laboratory equipment and rental of equipment for clinical studies. Operating cash flow... ► Artikel lesen | |
| 11.07. | ADDVISE GROUP AB: ADDvise publishes prospectus and applies for admission to trading of bonds on Nasdaq Stockholm | 2 | Cision News | ||
| 09.07. | ADDVISE GROUP AB: Invitation to presentation of interim report April 1 - June 30, 2025 | 1 | Cision News | ||
| 26.05. | ADDvise Group AB (publ): ADDvise enters into facilities agreement with Nordea - reduces financial costs by approximately SEK 56 million per year | 1.582 | GlobeNewswire (Europe) | ADDvise Group AB (publ) has entered into a new secured facilities agreement with Nordea Bank Abp, filial i Sverige, with a total limit of SEK 450 million. As previously communicated, the company will... ► Artikel lesen | |
| 12.05. | ADDvise Group AB (publ): Johan Irwe is appointed CFO, Staffan Torstensson (also CEO) assumes role as Head of the Healthcare segment, and Fredrik Mella departs | 155 | GlobeNewswire (Europe) | Since July 2024, Johan Irwe has served as interim CFO and has delivered strong results in the role. With his sharp analytical skills and dedicated leadership, Johan has created significant value for... ► Artikel lesen | |
| 12.05. | ADDvise Group AB (publ): Report from the annual general meeting of ADDvise Group AB (publ) on 12 May 2025 | 166 | GlobeNewswire (Europe) | ADDvise Group AB (publ), reg. no. 556363-2115, has today, on 12 May 2025, held its annual general meeting at the company's premises at Grev Turegatan 30 in Stockholm. At the meeting it was resolved... ► Artikel lesen | |
| 09.05. | ADDvise Group AB (publ): Interim report 2025, January 1-March 31 | 167 | GlobeNewswire (Europe) | In the first quarter of 2025, net revenue increased organically with continued good profitability, which shows stable demand in medical technology and laboratory solutions. Cash flow from operating... ► Artikel lesen | |
| 24.04. | New equity right for trading, ADDvise Group AB | 237 | GlobeNewswire | At the request of ADDvise Group AB, equity rights will be traded on First North Growth Market as from 25 April 2025.
Security name:
ADDvise Group AB TO 1 A
Short... ► Artikel lesen | |
| 18.03. | XFRA CAPITAL ADJUSTMENT INFORMATION - 18.03.2025 | 720 | Xetra Newsboard | Das Instrument 0A3 NL0015000RT3 NEPI ROCKCASTLE EO -,01 EQUITY wird cum Kapitalmassnahme gehandelt am 18.03.2025 und ex Kapitalmassnahme am 19.03.2025 The instrument 0A3 NL0015000RT3 NEPI ROCKCASTLE... ► Artikel lesen | |
| 12.03. | ADDvise Group AB (publ): Report from the extra ordinary general meeting in ADDvise Group AB (publ) | 361 | GlobeNewswire (Europe) | ADDvise Group AB (publ), reg. no. 556363-2115 (the "Company"), has held an extraordinary general meeting on 12 March 2025. The general meeting resolved to amend the articles of association, approve... ► Artikel lesen | |
| 20.02. | ADDvise Group AB (publ): Year-end report 2024, January 1-December 31 | 243 | GlobeNewswire (Europe) | The fourth quarter of 2024 showed a turnaround in organic net revenue. In December alone, we are now back at positive organic growth of 4.8%. With new long-term financial targets, we are now taking... ► Artikel lesen |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 40,710 | -0,22 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,500 | -0,54 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat Siemens Healthineers mit "Outperform" und einem Kursziel von 52,90 Euro in die Bewertung wieder aufgenommen. Nach einem für die... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 40,300 | +0,15 % | DZ BANK stuft CARL ZEISS MEDITEC AG auf 'Halten' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Aktienwert von Carl Zeiss Meditec von 57 auf 42 Euro gesenkt, aber die Einstufung auf "Halten" belassen. Die Jenaer hätten im Geschäftsjahr... ► Artikel lesen | |
| UNITEDHEALTH | 275,30 | -0,43 % | Unitedhealth: Eine Aktie, die jetzt noch unter ihrem fairen Wert liegt | © Foto: wallstreetonline/KI - OpenAINach dem KI-Trade schauen die Anleger wieder gezielt nach unterbewerteten Aktien. Viele sind hinter ihrer Bewertung zurückgeblieben, wie United Health.Am Markt ist... ► Artikel lesen | |
| MEDTRONIC | 82,71 | -0,49 % | Medtronic's Diabetes Unit MiniMed Files For IPO On Nasdaq | WASHINGTON (dpa-AFX) - Medtronic plc (MDT) announced that its Diabetes division-set to operate under the name MiniMed-has filed a registration statement on Form S-1 with the U.S. Securities... ► Artikel lesen | |
| INTUITIVE SURGICAL | 489,40 | -0,79 % | Intuitive Surgical Earnings Preview: What to Expect | ||
| THERMO FISHER | 491,25 | +0,32 % | Favorable Results and Improved Guidance Lifted Thermo Fisher Scientific (TMO) in Q3 | ||
| TELADOC HEALTH | 6,044 | -2,20 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Financial Officer Transition | NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced that Mala Murthy will be stepping down from her role as Chief Financial... ► Artikel lesen | |
| HIMS & HERS HEALTH | 29,330 | -1,54 % | Hims & Hers Expands Subscription-Led Care as Platform Engagement Grows | ||
| BICO GROUP | 1,763 | +1,67 % | BICO Group AB: Jesper Hagberg appointed as Chief Operations & Digital Officer for BICO Group AB | BICO Group AB today announces the appointment of Jesper Hagberg as Chief Operations & Digital Officer.
Jesper Hagberg brings over 25 years of experience as CIO, CDO and Transformation Leader, driving... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 61,80 | -0,29 % | Eurofins: Weekly Report on Share Repurchases from 15th December to 19th December 2025 | Regulatory News:
Eurofins (Paris:ERF):
Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily... ► Artikel lesen | |
| BECTON DICKINSON | 165,60 | -1,08 % | BD faces hernia mesh lawsuit from Tela Bio | ||
| ALIGN TECHNOLOGY | 132,75 | -2,03 % | TECX, GKOS, GH, ALGN, NMRA Surge After Hours On Clinical Data And Earnings | WASHINGTON (dpa-AFX) - Several healthcare and life sciences names posted notable gains in after-hours trading, driven by clinical updates, earnings releases, and in some cases, unexplained momentum.Tectonic... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,020 | +5,32 % | NuGen Medical: Kurs explodiert nach wichtiger News! | ||
| INMODE | 12,190 | -0,73 % | InMode Ltd.: InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins | YOKNEAM, Israel, Nov. 5, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen |
ADDVISE GROUP AB gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +9,05 % bei einem Aktienkurs von 0,130 Euro. Beim derzeitigen Kurs ergibt sich, basierend auf einer gesamten Ausschüttung von 0,00 Euro in den vergangenen 12 Monaten, eine Dividendendrendite von 0,00 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ADDVISE GROUP AB finden Sie auf Wallstreet Online.